Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2020

08.02.2020 | Glaucoma

Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma

verfasst von: Niten Vig, Sally Ameen, Philip Bloom, Laura Crawley, Eduardo Normando, Alastair Porteous, Faisal Ahmed

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study evaluates the 6-month safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in cases of uncontrolled glaucoma/ocular hypertension using a reduced energy protocol.

Methods

Retrospective analysis of patients undergoing MP-TSCPC from January–April 2018 was carried out. Patients received up to 90 s of laser with settings of 2000 mW/Cm2 and a duty cycle of 31.3%.

Results

A total of 29 patients were included, with a mean age of 64.7 ± 15.1 years. The most common diagnosis was primary open angle glaucoma (41.4%) with a mean Logmar visual acuity of 1.5 ± 1.2. All subjects had either undergone intraocular surgery (58.6% filtration surgery) or continuous wave diode laser prior to micropulse treatment. Mean pre-laser IOP was 26.2 ± 11.1 mmHg. There was a significant reduction (p < 0.05) in IOP at 1 month to 15.8 ± 5.4 mmHg (39.7% reduction), at 3 months to 15.04 ± 5.25 mmHg (42.6% reduction) and at 6 months to 18.19 ± 7.47 mmHg (30.6% reduction). There was also a corresponding reduction (p < 0.05) in the number of topical agents required to control pressure from a baseline of 3.31 ± 0.97, to 2.72 ± 0.88 at 1 month, 2.76 ± 0.91 at 3 months and 2.90 ± 1.08 at 6 months. Requirements for oral acetazolamide reduced from 41.3% (1/29) at baseline to 3.4% (1/29) at 6 months. Success rates were 75.9% at 1 month, 79.3% at 3 months and 58.6% at 6 months. There was no drop in the visual acuity, no change in central retinal thickness and no cases of intraocular inflammation.

Conclusions

MP-TSCPC at a decreased duration is effective at reducing intraocular pressure in ethnically diverse glaucoma patients refractory to previous glaucoma laser or surgeries at 6 months follow-up, with no significant complications. Further work is needed to confirm efficacy in the long term and to determine optimal settings.
Literatur
1.
Zurück zum Zitat Flaxman SR, Bourne RRA, Resnikoff S et al (2017) Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health 5(12):e1221–e1234CrossRef Flaxman SR, Bourne RRA, Resnikoff S et al (2017) Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health 5(12):e1221–e1234CrossRef
2.
Zurück zum Zitat Boland MV, Ervin A-M, Friedman DS et al. (2013) Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med Feb 19;158(4):271–9 Boland MV, Ervin A-M, Friedman DS et al. (2013) Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med Feb 19;158(4):271–9
3.
Zurück zum Zitat Clement CI, Kampougeris G, Ahmed F et al. (2013) Combining phacoemulsification with endoscopic cyclophotocoagulation to manage cataract and glaucoma. Clin xperiment Ophthalmol. Aug;41(6):546–51 Clement CI, Kampougeris G, Ahmed F et al. (2013) Combining phacoemulsification with endoscopic cyclophotocoagulation to manage cataract and glaucoma. Clin xperiment Ophthalmol. Aug;41(6):546–51
4.
Zurück zum Zitat Bloom PA, Dharmaraj S (2006) Endoscopic and transscleral cyclophotocoagulation. Br J Ophthalmol Jun 90(6):666–668CrossRef Bloom PA, Dharmaraj S (2006) Endoscopic and transscleral cyclophotocoagulation. Br J Ophthalmol Jun 90(6):666–668CrossRef
5.
Zurück zum Zitat Feldman RM, el-Harazi SM, LoRusso FJ et al. (1997) Histopathologic findings following contact transscleral semiconductor diode laser cyclophotocoagulation in a human eye. J Glaucoma Apr;6(2):139–140 Feldman RM, el-Harazi SM, LoRusso FJ et al. (1997) Histopathologic findings following contact transscleral semiconductor diode laser cyclophotocoagulation in a human eye. J Glaucoma Apr;6(2):139–140
6.
Zurück zum Zitat Pantcheva MB, Kahook MY, Schuman JS et al.(2007) Comparison of acute structural and histopathological changes of the porcine ciliary processes after endoscopic cyclophotocoagulation and transscleral cyclophotocoagulation. Clin Experiment Ophthalmol. Apr;35(3):270–4 Pantcheva MB, Kahook MY, Schuman JS et al.(2007) Comparison of acute structural and histopathological changes of the porcine ciliary processes after endoscopic cyclophotocoagulation and transscleral cyclophotocoagulation. Clin Experiment Ophthalmol. Apr;35(3):270–4
7.
Zurück zum Zitat Kosoko O, Gaasterland DE, Pollack IP et al. (1996) Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group. Ophthalmology. Aug;103(8):1294–302 Kosoko O, Gaasterland DE, Pollack IP et al. (1996) Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group. Ophthalmology. Aug;103(8):1294–302
8.
Zurück zum Zitat Pastor SA, Singh K, Lee DA, et al.(2001) Cyclophotocoagulation: a report by the American Academy of Ophthalmology. Ophthalmology. Nov;108(11):2130–8 Pastor SA, Singh K, Lee DA, et al.(2001) Cyclophotocoagulation: a report by the American Academy of Ophthalmology. Ophthalmology. Nov;108(11):2130–8
9.
Zurück zum Zitat Aquino MC, Lim D, Chew PT. (2018) Micropulse P3™ (MP3) laser for Glaucoma: an innovative therapy. J Curr Glaucoma Pract. Aug;12(2):51–2 Aquino MC, Lim D, Chew PT. (2018) Micropulse P3™ (MP3) laser for Glaucoma: an innovative therapy. J Curr Glaucoma Pract. Aug;12(2):51–2
10.
Zurück zum Zitat Tan AM, Chockalingam M, Aquino MC et al. (2010) Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Experiment Ophthalmol. Apr;38(3):266–72 Tan AM, Chockalingam M, Aquino MC et al. (2010) Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Experiment Ophthalmol. Apr;38(3):266–72
11.
Zurück zum Zitat Emanuel ME, Grover DS, Fellman RL et al (2017) Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma Aug 26(8):726–729CrossRef Emanuel ME, Grover DS, Fellman RL et al (2017) Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma Aug 26(8):726–729CrossRef
12.
Zurück zum Zitat Zaarour K, Abdelmassih Y, Arej N et al (2019) Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients. J Glaucoma Mar 28(3):270–275CrossRef Zaarour K, Abdelmassih Y, Arej N et al (2019) Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients. J Glaucoma Mar 28(3):270–275CrossRef
13.
Zurück zum Zitat Gupta B, Elagouz M, McHugh D et al. (2009) Micropulse diode laser photocoagulation for central serous chorio-retinopathy. Clin Experiment Ophthalmol. Nov;37(8):801–5 Gupta B, Elagouz M, McHugh D et al. (2009) Micropulse diode laser photocoagulation for central serous chorio-retinopathy. Clin Experiment Ophthalmol. Nov;37(8):801–5
14.
Zurück zum Zitat Amoozgar B, Phan EN, Lin SC et al. (2017) Update on ciliary body laser procedures. Curr Opin Ophthalmol. Mar;28(2):181–6 Amoozgar B, Phan EN, Lin SC et al. (2017) Update on ciliary body laser procedures. Curr Opin Ophthalmol. Mar;28(2):181–6
15.
Zurück zum Zitat Williams AL, Moster MR, Rahmatnejad K et al (2018) Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma May 27(5):445–449CrossRef Williams AL, Moster MR, Rahmatnejad K et al (2018) Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma May 27(5):445–449CrossRef
16.
Zurück zum Zitat Kuchar S, Moster MR, Reamer CB et al. (2016) Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma. Lasers Med Sci. Feb;31(2):393–6 Kuchar S, Moster MR, Reamer CB et al. (2016) Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma. Lasers Med Sci. Feb;31(2):393–6
17.
Zurück zum Zitat Jabs DA, Nussenblatt RB, Rosenbaum JT. (2005) Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. Sep;140(3):509–16 Jabs DA, Nussenblatt RB, Rosenbaum JT. (2005) Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. Sep;140(3):509–16
18.
Zurück zum Zitat Varikuti VNV, Shah P, Rai O et al (2019) Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision. J Glaucoma Oct 28(10):901–905CrossRef Varikuti VNV, Shah P, Rai O et al (2019) Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision. J Glaucoma Oct 28(10):901–905CrossRef
Metadaten
Titel
Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma
verfasst von
Niten Vig
Sally Ameen
Philip Bloom
Laura Crawley
Eduardo Normando
Alastair Porteous
Faisal Ahmed
Publikationsdatum
08.02.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2020
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-020-04611-0

Weitere Artikel der Ausgabe 5/2020

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Open Access 22.02.2024 | Peeling | Originalien

Selektive Vitalfarbstoffe in der Makulachirurgie

Erhöhen sie die Wahrscheinlichkeit der intraoperativen ILM-Identifizierung auch bei einem erfahrenen Operateur?

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.